BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38043713)

  • 1. How Well Does the EQ-5D-Y-5L Describe Children With Intellectual Disability?: "There's a Lot More to My Child Than That She Can't Wash or Dress Herself.".
    Blackmore AM; Mulhern B; Norman R; Reddihough D; Choong CS; Jacoby P; Downs J
    Value Health; 2024 Feb; 27(2):190-198. PubMed ID: 38043713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychometric Properties of the EQ-5D-Y-5L for Children With Intellectual Disability.
    Downs J; Norman R; Mulhern B; Jacoby P; Reddihough D; Choong CS; Finlay-Jones A; Blackmore AM
    Value Health; 2024 Jun; 27(6):776-783. PubMed ID: 38467188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EQ-5D-Y-3L and EQ-5D-Y-5L proxy report: psychometric performance and agreement with self-report.
    Fitriana TS; Purba FD; Stolk E; Busschbach JJV
    Health Qual Life Outcomes; 2022 Jun; 20(1):88. PubMed ID: 35659313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Comparison of the Psychometric Properties of the EQ-5D-Y-3L and EQ-5D-Y-5L Using Paediatric Multi-Instrument Comparison (P-MIC) Study Data.
    Bahrampour M; Devlin N; Jones R; Dalziel K; Mulhern B;
    Pharmacoeconomics; 2024 Jun; 42(Suppl 1):95-111. PubMed ID: 38748193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Development of the German version of EQ-5D-Y-5L to measure health-related quality of life in children and adolescents: Identification of response labels and pilot testing].
    Kreimeier S; Greiner W
    Z Evid Fortbild Qual Gesundhwes; 2019 Aug; 144-145():24-34. PubMed ID: 31378708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life amongst primary caregivers of children with intellectual disability.
    Arora S; Goodall S; Viney R; Einfeld S;
    J Intellect Disabil Res; 2020 Feb; 64(2):103-116. PubMed ID: 31840365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing the psychometric properties of EQ-5D-3L and EQ-5D-5L proxy ratings by informal caregivers and a health professional for people with dementia.
    Michalowsky B; Hoffmann W; Mohr W; Rädke A; Xie F
    Health Qual Life Outcomes; 2022 Oct; 20(1):140. PubMed ID: 36199138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychometric performance of proxy-reported EQ-5D youth version 5-level (EQ-5D-Y-5L) in comparison with three-level (EQ-5D-Y-3L) in children and adolescents with scoliosis.
    Lin J; Wong CKH; Cheung JPY; Cheung PWH; Luo N
    Eur J Health Econ; 2022 Nov; 23(8):1383-1395. PubMed ID: 35122171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-Cultural Adaptation of the Beta EQ-5D-Y-5L Into Chichewa (Malawi).
    Ngwira LG; Jelsma J; Maheswaran H; Kapakasa F; Derrett S; Petrou S; Niessen L; Smith SC
    Value Health Reg Issues; 2022 May; 29():36-44. PubMed ID: 34801884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fighting to Breathe and Fighting for Health-Related Quality of Life: Measuring the Impact of Being Dependent on Technology for Breathing on the Child and Their Caregiver.
    Verstraete J; Booth C; Booth J; Peer S; McGuire J; Kritzinger F; Gray T; Zibi N; Shabangu P; Zampoli M
    Patient; 2024 Jan; 17(1):65-82. PubMed ID: 37991685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EQ-5D-Y-5L: developing a revised EQ-5D-Y with increased response categories.
    Kreimeier S; Åström M; Burström K; Egmar AC; Gusi N; Herdman M; Kind P; Perez-Sousa MA; Greiner W
    Qual Life Res; 2019 Jul; 28(7):1951-1961. PubMed ID: 30739287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-caregiver agreement and test-retest reliability of the EQ-5D-Y-3L and EQ-5D-Y-5L in paediatric patients with haematological malignancies.
    Zhou W; Shen A; Yang Z; Wang P; Wu B; Herdman M; Luo N
    Eur J Health Econ; 2021 Sep; 22(7):1103-1113. PubMed ID: 33950465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceptability of the health-related quality of life instrument EQ-5D-Y-5L among patients in child and adolescent psychiatric inpatient care.
    Krig S; Åström M; Kulane A; Burström K
    Acta Paediatr; 2021 Mar; 110(3):899-906. PubMed ID: 32815186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How Should We Capture Health State Utility in Dementia? Comparisons of DEMQOL-Proxy-U and of Self- and Proxy-Completed EQ-5D-5L.
    Martin A; Meads D; Griffiths AW; Surr CA
    Value Health; 2019 Dec; 22(12):1417-1426. PubMed ID: 31806199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychometric performance of the Chichewa versions of the EQ-5D-Y-3L and EQ-5D-Y-5L among healthy and sick children and adolescents in Malawi.
    Ngwira LG; Maheswaran H; Verstraete J; Petrou S; Niessen L; Smith SC
    J Patient Rep Outcomes; 2023 Mar; 7(1):22. PubMed ID: 36892714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Qualitative Investigation of Older Adults' Conceptualization of Quality of Life and a Think-Aloud Content Validation of the EQ-5D-5L, SF-12v2, Warwick Edinburgh Mental Wellbeing Scale, and Office of National Statistics-4.
    Penton H; Dayson C; Hulme C; Young T
    Value Health; 2022 Dec; 25(12):2017-2027. PubMed ID: 35760713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An empirical comparison of the measurement properties of the EQ-5D-5L, DEMQOL-U and DEMQOL-Proxy-U for older people in residential care.
    Easton T; Milte R; Crotty M; Ratcliffe J
    Qual Life Res; 2018 May; 27(5):1283-1294. PubMed ID: 29305782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Content validity of the EQ-5D-5L with skin irritation and self-confidence bolt-ons in patients with atopic dermatitis: a qualitative think-aloud study.
    Szlávicz E; Szabó Á; Kinyó Á; Szeiffert A; Bancsók T; Brodszky V; Gyulai R; Rencz F
    Qual Life Res; 2024 Jan; 33(1):101-111. PubMed ID: 37787930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The EQ-5D-5L Is Superior to the -3L Version in Measuring Health-related Quality of Life in Patients Awaiting THA or TKA.
    Jin X; Al Sayah F; Ohinmaa A; Marshall DA; Smith C; Johnson JA
    Clin Orthop Relat Res; 2019 Jul; 477(7):1632-1644. PubMed ID: 30801280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing validity of the EQ-5D-5L proxy in children and adolescents with Duchenne muscular dystrophy or spinal muscular atrophy.
    Xu RH; Dai Y; Ng SSM; Tsang HWH; Zhang S; Dong D
    Eur J Health Econ; 2024 Feb; 25(1):103-115. PubMed ID: 36809586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.